Cargando…
Armed Therapeutic Viruses – A Disruptive Therapy on the Horizon of Cancer Immunotherapy
For the past 150 years cancer immunotherapy has been largely a theoretical hope that recently has begun to show potential as a highly impactful treatment for various cancers. In particular, the identification and targeting of immune checkpoints have given rise to exciting data suggesting that this s...
Autores principales: | Bauzon, Maxine, Hermiston, Terry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932422/ https://www.ncbi.nlm.nih.gov/pubmed/24605114 http://dx.doi.org/10.3389/fimmu.2014.00074 |
Ejemplares similares
-
Oncolytic Viruses: The Power of Directed Evolution
por: Bauzon, Maxine, et al.
Publicado: (2012) -
OvAd1, a Novel, Potent, and Selective Chimeric Oncolytic Virus Developed for Ovarian Cancer by 3D-Directed Evolution
por: Kuhn, Irene, et al.
Publicado: (2016) -
In vitro characterization of CT‐001—a short‐acting factor VIIa with enhanced prohemostatic activity
por: Sim, Derek S., et al.
Publicado: (2021) -
Formulations for Allergen Immunotherapy in Human and Veterinary Patients: New Candidates on the Horizon
por: Pali-Schöll, Isabella, et al.
Publicado: (2020) -
Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer
por: Kuhn, Irene, et al.
Publicado: (2008)